ANTISTAX® Active Leg tablets. Reg. no.:48/32.2/1076.
Each tablet contains dry extract of red vine leaf AS 195 (4 - 6:1) 360 mg per tablet.
For full prescribing information refer to the professional information approved by the South African Health Products Regulatory Authority (SAHPRA).
ANTISTAX® Double Fresh Gel contains Red Vine Leaf Extract. Western herbal. This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.
Applicant: Imperial Market Access Healthcare SA (Pty) Ltd, 10 Skeen Boulevard Bedford view Gauteng, 2007, RSA.
Tel: 012 621 4300
General contact information:
info.mahsa.sm@dpworld.com
Side Effects/Safety:
quality.healthcare.sm@dpworld.com
Medical Queries:
pvimperiallogistics@dpworld.com
COPYRIGHT 2023 – Imperial Market Access Healthcare South Africa (Pty) Limited - ALL RIGHTS RESERVED
ANTISTAX® Active Leg tablets. Reg. no.:48/32.2/1076. Each tablet contains dry extract of red vine leaf AS 195 (4 - 6:1) 360 mg per tablet. For full prescribing information refer to the professional information approved by the South African Health Products Regulatory Authority (SAHPRA).
ANTISTAX® Double Fresh Gel contains Red Vine Leaf Extract. Western herbal. This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.
HCR: Imperial Market Access Healthcare SA (Pty) Ltd, 10 Skeen Boulevard, Bedfordview, Gauteng, 2007. Reg. no.: 2006/029994/07.
General contact information: info.mahsa.sm@dpworld.com Tel: 012 621 4300. For any quality or safety related queries, please contact Imperial Quality at Quality.healthcare.sm@dpworld.com or Imperial Medical at pvimperiallogistics@dpworld.com.
References: 1. Antistax PIL 2. Antistax Double Fresh Gel PIL 3. Kiesewetter H. Koscielny J, Kalus U et al. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II): a randomised, double-blind, placebo-controlled trial. Arzneim.-Forsch./Drug Res 2000;50(1):109-117. 4. Kalus U, Koscielny J, Grigorov A et al. Improvement of cutaneous microcirculation and oxygen supply in patients with Chronic Venous Insufficiency by orally administered extract of red vine leaves AS 195: a randomised, double-blind, placebo-controlled, crossover study. Drugs R&D 2004; 5(2): 63-71. 5. Nees S, Weiss DR, Reichenblach-Klinke E et al. Protective Effects of Flavonoids Contained in the Red Vine Leaf on Venular Endothelium against the Attack of Activated Blood Components in vitro. Arzneim.-Forsch./Drug Res. 2003;53(5):330-341. 6. (last accessed 12 December 2023) 7. Francoise Pitsch. Results of the DECIDE survey: appraisal of the predictive value for chronic venous disease of a symptom. Phlebolymphology Vol 18. No. 3. 2011 8. NCBI - WWW Error Blocked Diagnostic (last accessed 13 December 2023) 9. The Epidemiology of Chronic Venous Insufficiency and Varicose Veins by Jennifer L. Beebe-Dimmer, John R Pfeifer, Jennifer S. Engle and David Schottenfeld. March 2005 SAZA.ANTI.19.08.0315